Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and Review

Background. Mast cell leukaemia is a unique disease among hematopoietic neoplasms, being one of the rarest leukaemia subtypes. In addition, its prompt diagnosis is usually challenging. This is due to its heterogeneity in clinical presentations and cytomorphological and immunophenotypical features to...

Full description

Saved in:
Bibliographic Details
Main Authors: Dina Sameh Soliman, Ahmad Al-Sabbagh, Feryal Ibrahim, Amna Gameil, Mohamed Yassin, Halima El-Omri
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2019/1805270
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548735827050496
author Dina Sameh Soliman
Ahmad Al-Sabbagh
Feryal Ibrahim
Amna Gameil
Mohamed Yassin
Halima El-Omri
author_facet Dina Sameh Soliman
Ahmad Al-Sabbagh
Feryal Ibrahim
Amna Gameil
Mohamed Yassin
Halima El-Omri
author_sort Dina Sameh Soliman
collection DOAJ
description Background. Mast cell leukaemia is a unique disease among hematopoietic neoplasms, being one of the rarest leukaemia subtypes. In addition, its prompt diagnosis is usually challenging. This is due to its heterogeneity in clinical presentations and cytomorphological and immunophenotypical features together with potential associations with other hematologic neoplasms which can complicate the condition and delay accurate diagnosis. To the best of our knowledge, this is the first case report of CD4-positive mast cell leukaemia. Case Presentation. A 39-year-old male presented with acute onset of fever, abdominal pain, and generalized body aches of two-week duration. Peripheral blood smear showed circulating blasts (13%) with coarsely basophilic granulation. Bone marrow (BM) aspirate showed extensive infiltration with immature mast cells of blast-like morphology with trilineage dysplasia and evident hemophagocytic activity exhibited by histiocytes and neoplastic mast cells. BM biopsy was diffusely infiltrated with many atypical mast cells positive for CD45, CD117, mast cell tryptase, CD25, and CD4 with partial positivity for CD7 and CD30. Cytogenetics showed an abnormal karyotype: 47, XY, +1947, XY, +19[13]/46, XY[9]. Molecular analysis revealed a KIT D816V mutation consistent with a diagnosis of systemic mastocytosis, mast cell leukaemia. Conclusion. The expression of T-cell associated markers by abnormal mast cells is well documented; however, CD4 and CD7 expression have not previously been described in association with mast cell leukaemia. Coexpression of CD2, CD4, CD7, and CD30 by the mast cells particularly in skin lesions may provoke misinterpretation as a cutaneous T-cell neoplasm. To the best of our knowledge, this is the first report of CD4-positive mast cell leukaemia. Moreover, hemophagocytic mast cell leukaemia is a very rare morphologic variant, and possible correlation between this finding and expression of CD4 by neoplastic mast cells is a topic for further investigation.
format Article
id doaj-art-7c2e44a17968499cb2aebfdffdb87b99
institution Kabale University
issn 2090-6560
2090-6579
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-7c2e44a17968499cb2aebfdffdb87b992025-02-03T06:13:12ZengWileyCase Reports in Hematology2090-65602090-65792019-01-01201910.1155/2019/18052701805270Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and ReviewDina Sameh Soliman0Ahmad Al-Sabbagh1Feryal Ibrahim2Amna Gameil3Mohamed Yassin4Halima El-Omri5Department of Laboratory Medicine and Pathology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, QatarDepartment of Laboratory Medicine and Pathology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, QatarDepartment of Laboratory Medicine and Pathology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, QatarDepartment of Hematology and Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, QatarDepartment of Hematology and Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, QatarDepartment of Hematology and Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, QatarBackground. Mast cell leukaemia is a unique disease among hematopoietic neoplasms, being one of the rarest leukaemia subtypes. In addition, its prompt diagnosis is usually challenging. This is due to its heterogeneity in clinical presentations and cytomorphological and immunophenotypical features together with potential associations with other hematologic neoplasms which can complicate the condition and delay accurate diagnosis. To the best of our knowledge, this is the first case report of CD4-positive mast cell leukaemia. Case Presentation. A 39-year-old male presented with acute onset of fever, abdominal pain, and generalized body aches of two-week duration. Peripheral blood smear showed circulating blasts (13%) with coarsely basophilic granulation. Bone marrow (BM) aspirate showed extensive infiltration with immature mast cells of blast-like morphology with trilineage dysplasia and evident hemophagocytic activity exhibited by histiocytes and neoplastic mast cells. BM biopsy was diffusely infiltrated with many atypical mast cells positive for CD45, CD117, mast cell tryptase, CD25, and CD4 with partial positivity for CD7 and CD30. Cytogenetics showed an abnormal karyotype: 47, XY, +1947, XY, +19[13]/46, XY[9]. Molecular analysis revealed a KIT D816V mutation consistent with a diagnosis of systemic mastocytosis, mast cell leukaemia. Conclusion. The expression of T-cell associated markers by abnormal mast cells is well documented; however, CD4 and CD7 expression have not previously been described in association with mast cell leukaemia. Coexpression of CD2, CD4, CD7, and CD30 by the mast cells particularly in skin lesions may provoke misinterpretation as a cutaneous T-cell neoplasm. To the best of our knowledge, this is the first report of CD4-positive mast cell leukaemia. Moreover, hemophagocytic mast cell leukaemia is a very rare morphologic variant, and possible correlation between this finding and expression of CD4 by neoplastic mast cells is a topic for further investigation.http://dx.doi.org/10.1155/2019/1805270
spellingShingle Dina Sameh Soliman
Ahmad Al-Sabbagh
Feryal Ibrahim
Amna Gameil
Mohamed Yassin
Halima El-Omri
Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and Review
Case Reports in Hematology
title Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and Review
title_full Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and Review
title_fullStr Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and Review
title_full_unstemmed Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and Review
title_short Highly Aggressive CD4-Positive Mast Cell Leukaemia (Leukaemic Variant) Associated with Isolated Trisomy 19 and Hemophagocytosis by Neoplastic Mast Cells: A Case Report with Challenging Experience and Review
title_sort highly aggressive cd4 positive mast cell leukaemia leukaemic variant associated with isolated trisomy 19 and hemophagocytosis by neoplastic mast cells a case report with challenging experience and review
url http://dx.doi.org/10.1155/2019/1805270
work_keys_str_mv AT dinasamehsoliman highlyaggressivecd4positivemastcellleukaemialeukaemicvariantassociatedwithisolatedtrisomy19andhemophagocytosisbyneoplasticmastcellsacasereportwithchallengingexperienceandreview
AT ahmadalsabbagh highlyaggressivecd4positivemastcellleukaemialeukaemicvariantassociatedwithisolatedtrisomy19andhemophagocytosisbyneoplasticmastcellsacasereportwithchallengingexperienceandreview
AT feryalibrahim highlyaggressivecd4positivemastcellleukaemialeukaemicvariantassociatedwithisolatedtrisomy19andhemophagocytosisbyneoplasticmastcellsacasereportwithchallengingexperienceandreview
AT amnagameil highlyaggressivecd4positivemastcellleukaemialeukaemicvariantassociatedwithisolatedtrisomy19andhemophagocytosisbyneoplasticmastcellsacasereportwithchallengingexperienceandreview
AT mohamedyassin highlyaggressivecd4positivemastcellleukaemialeukaemicvariantassociatedwithisolatedtrisomy19andhemophagocytosisbyneoplasticmastcellsacasereportwithchallengingexperienceandreview
AT halimaelomri highlyaggressivecd4positivemastcellleukaemialeukaemicvariantassociatedwithisolatedtrisomy19andhemophagocytosisbyneoplasticmastcellsacasereportwithchallengingexperienceandreview